Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Reperfusion Therapy With Intravenous Thrombolysis for Recovery of VISION in Acute Central Retinal Artery Occlusion

NCT04965038 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.

NCT NCT04965038
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04965038 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Reperfusion Therapy With Intravenous Thrombolysis for Recovery of VISION in Acute Central Retinal Artery Occlusion
Lead sponsor
University Hospital Tuebingen
Phase
Phase 3
Overall status
Terminated
Start date
October 10, 2022
Completion date
April 29, 2026
Enrollment
127 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

central retinal artery occlusion